aXichem
2.76
SEK
-1.08 %
Less than 1K followers
AXIC A
First North Stockholm
Chemicals
Basic Materials
Overview
Ownership
Investor consensus
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.
Read moreMarket cap
163.16M SEK
Turnover
38.69K SEK
Revenue
8.57M
EBIT %
-184.71 %
P/E
-
Dividend yield-%
-
Financial calendar
18/6
2025
General meeting '25
28/8
2025
Interim report Q2'25
28/11
2025
Interim report Q3'25
All
Press releases
3rd party
ShowingAll content types
aXichem AB: aXichem announces positive results of completed efficacy studies, as well as time for submission of supplemented Feed Additive application in the EU
aXichem AB (publ) publicerar Årsredovisning 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools